Common Contracts
159 similar Underwriting Agreement contracts by BioXcel Therapeutics, Inc., In8bio, Inc., Palomar Holdings, Inc., others
Common Stock, par value $1.00 per share UNDERWRITING AGREEMENTUnderwriting Agreement • November 1st, 2024 • Mid Penn Bancorp Inc • State commercial banks • New York
As part of the offering contemplated by this Agreement, Piper Sandler & Co. (the “Designated Underwriter”) has agreed to reserve out of the Firm Stock purchased by it under this Agreement, up to 2.0% of the shares for sale to the Company’s directors, employees and other parties associated with the Company (collectively, the “Directed Share Participants”), as set forth in the Prospectus (as defined herein) under the heading “Underwriting” (the “Directed Share Program”) and subject to the applicable rules, regulations and interpretations of the Financial Industry Regulatory Authority, Inc. (“FINRA”). The Firm Stock to be sold by the Designated Underwriter pursuant to the Directed Share Program (the “Directed Shares”) will be sold by the Designated Underwriter pursuant to this Agreement at the public offering price. Any Directed Shares not purchased through the Directed Share Program will be offered to the public by the Underwriters.
] shares KINDERCARE LEARNING COMPANIES, INC. Shares of Common Stock (par value $0.01 per share) UNDERWRITING AGREEMENTUnderwriting Agreement • September 30th, 2024 • KinderCare Learning Companies, Inc. • Services-child day care services • New York
KinderCare Learning Companies, Inc., a Delaware corporation (the “Company”), proposes to sell an aggregate of [•] shares (the “Firm Stock”) of Company’s common stock, par value $0.01 per share (the “Common Stock”). In addition, the Company proposes to grant to the underwriters named in Schedule I (the “Underwriters”) attached to this agreement (this “Agreement”) an option to purchase up to an aggregate of [•] additional shares of the Common Stock on the terms set forth in Section 3 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock”. This Agreement is to confirm the agreement concerning the purchase of the Stock from KinderCare by the Underwriters.
1,200,000 Shares of Common Stock Palomar Holdings, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • August 9th, 2024 • Palomar Holdings, Inc. • Fire, marine & casualty insurance • New York
Palomar Holdings, Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters listed in Schedule I hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 1,200,000 shares (the “Firm Stock”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). In addition, the Company proposes to grant to the Underwriters an option to purchase up to 180,000 additional shares of the Common Stock on the terms set forth in Section 2 hereto (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock”. This underwriting agreement (this “Agreement”) is to confirm the agreement concerning the purchase of the Stock from the Company by the Underwriters.
25,000,000 Shares of Common Stock ALLEGRO MICROSYSTEMS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • July 26th, 2024 • Allegro Microsystems, Inc. • Semiconductors & related devices • New York
Barclays Capital Inc. Morgan Stanley & Co. LLC, As Representatives of the several Underwriters named in Schedule I attached hereto,
UNDERWRITING AGREEMENTUnderwriting Agreement • November 14th, 2023 • Chesapeake Utilities Corp • Natural gas transmisison & distribution • New York
Chesapeake Utilities Corporation, a Delaware corporation (the “Company”), proposes to sell 3,859,649 shares (the “Firm Stock”) of the Company’s common stock, par value $0.4867 per share (the “Common Stock”). In addition, the Company proposes to grant to the underwriters named in Schedule I (the “Underwriters”) attached to this agreement (this “Agreement”) an option to purchase up to an aggregate of 578,947 additional shares of the Common Stock on the terms set forth in Section 2 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock”. This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company by the Underwriters.
BLINK CHARGING CO. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 7th, 2023 • Blink Charging Co. • Miscellaneous transportation equipment • New York
Enviva Inc. 4,300,000 Shares of Common Stock par value $0.001 per share UNDERWRITING AGREEMENTUnderwriting Agreement • January 21st, 2022 • Enviva Inc. • Lumber & wood products (no furniture) • New York
Enviva Inc., a Delaware corporation (the “Company”), proposes to sell 4,300,000 shares (the “Firm Stock”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). In addition, the Company proposes to grant to the underwriters (the “Underwriters”) named in Schedule I attached to this agreement (this “Agreement”) an option to purchase up to 645,000 additional shares of Common Stock on the terms set forth in Section 2 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock”. This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company by the Underwriters. Certain terms used in this Agreement are defined below in Section 1(a) hereof.
⚫ ] shares of Common Stock LATHAM GROUP, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • January 4th, 2022 • Latham Group, Inc. • Plastics products, nec • New York
Latham Group, Inc., a Delaware corporation (the “Company”), proposes to sell [ ⚫ ] shares (the “Firm Stock”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). In addition, the Company proposes to grant to the underwriters named in Schedule I (the “Underwriters”) attached to this agreement (this “Agreement”) an option to purchase up to an aggregate of [ ⚫ ] additional shares of the Common Stock on the terms set forth in Section 2 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock”. This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company by the Underwriters.
IN8BIO, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • July 20th, 2021 • In8bio, Inc. • Biological products, (no disgnostic substances) • New York
Common Stock, par value $1.00 per share UNDERWRITING AGREEMENTUnderwriting Agreement • May 3rd, 2021 • Mid Penn Bancorp Inc • State commercial banks • New York
The Company and the Bank confirm as follows their respective agreements with the Representative and the several other Underwriters.
•] shares of Common Stock Aveanna Healthcare Holdings Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • April 20th, 2021 • Aveanna Healthcare Holdings, Inc. • Services-home health care services • New York
Aveanna Healthcare Holdings Inc., a Delaware corporation (the “Company”), proposes to sell [•] shares (the “Firm Stock”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”). In addition, the Company proposes to grant to the underwriters named in Schedule I (the “Underwriters”) attached to this agreement (this “Agreement”) an option to purchase up to [•] additional shares of the Common Stock on the terms set forth in Section 3 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock”. This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company by the Underwriters.
● ] shares of Common Stock LATHAM GROUP, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • April 14th, 2021 • Latham Group, Inc. • Plastics products, nec • New York
Latham Group, Inc., a Delaware corporation (the “Company”), proposes to sell [ ● ] shares (the “Firm Stock”) of the Company’s common stock, par value $[ ● ] per share (the “Common Stock”). In addition, the Company proposes to grant to the underwriters named in Schedule I (the “Underwriters”) attached to this agreement (this “Agreement”) an option to purchase up to an aggregate of [ ● ] additional shares of the Common Stock on the terms set forth in Section 2 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock”. This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company by the Underwriters.
IN8BIO, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • March 31st, 2021 • In8bio, Inc. • Biological products, (no disgnostic substances) • New York
•] Shares Sun Country Airlines Holdings, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • March 8th, 2021 • Sun Country Airlines Holdings, Inc. • Air transportation, scheduled • New York
Sun Country Airlines Holdings, Inc., a Delaware corporation (the “Company”), proposes to sell an aggregate of [•] shares (the “Firm Stock”) of the Company’s common stock, par value $[•] per share (the “Common Stock”). In addition, the Company proposes to grant to the underwriters named in Schedule I (the “Underwriters”) attached to this agreement (this “Agreement”) an option to purchase up to an aggregate of [•] additional shares of the Common Stock on the terms set forth in Section 2 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock”. This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company by the Underwriters.
Shares NexImmune, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 8th, 2021 • NexImmune, Inc. • Pharmaceutical preparations • New York
NexImmune, Inc., a Delaware corporation (the “Company”), proposes to sell [__] shares (the “Firm Stock”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). In addition, the Company proposes to grant to the underwriters (the “Underwriters”) named in Schedule I attached to this agreement (this “Agreement”) an option to purchase up to [__] additional shares of the Common Stock on the terms set forth in Section 2 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock”. This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company by the Underwriters.
SILVERGATE CAPITAL CORPORATION Common Stock, par value $0.01 per share UNDERWRITING AGREEMENTUnderwriting Agreement • January 25th, 2021 • Silvergate Capital Corp • State commercial banks • New York
IN8BIO, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • November 5th, 2020 • In8bio, Inc. • Biological products, (no disgnostic substances) • New York
IN8bio, Inc., a Delaware corporation (the “Company”), proposes to sell [●] shares (the “Firm Stock”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). In addition, the Company proposes to grant to the underwriters named in Schedule I (the “Underwriters”) attached to this agreement (this “Agreement”) an option to purchase up to [●] additional shares of the Common Stock on the terms set forth in Section 3 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock”. This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company by the Underwriters.
• ] shares of Common Stock ALLEGRO MICROSYSTEMS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • October 21st, 2020 • Allegro Microsystems Inc • Semiconductors & related devices • New York
Allegro MicroSystems, Inc., a Delaware corporation (the “Company”), propose to sell [•] shares (the “Firm Stock”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”). In addition, certain stockholders of the Company named in Schedule II attached hereto (the “Selling Stockholders”) propose to grant to the underwriters named in Schedule I (the “Underwriters”) attached to this agreement (this “Agreement”) an option to purchase up to an aggregate of [•] additional shares of the Common Stock on the terms set forth in Section 3 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock.” This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company and the Selling Stockholders by the Underwriters.
Palomar Holdings, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • June 24th, 2020 • Palomar Holdings, Inc. • Fire, marine & casualty insurance • New York
Execution Version ANTERO RESOURCES CORPORATION Common Stock UNDERWRITING AGREEMENT March 5, 2015 CREDIT SUISSE SECURITIES (USA) LLC Eleven Madison Avenue New York, New York, 10010 As Representative of the several Underwriters named in Schedule I...Underwriting Agreement • May 5th, 2020 • New York
Antero Resources Corporation, a Delaware corporation (the “Company”), proposes to sell 13,100,000 shares (the “Firm Stock”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”). In addition, the Company proposes to grant to the underwriters (the “Underwriters”) named in Schedule I attached to this agreement (this “Agreement”) an option to purchase up to 1,900,000 additional shares of the Common Stock on the terms set forth in Section 2 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock.” To the extent there are no additional Underwriters listed on Schedule I other than you, the terms “Representatives” and “Underwriters” as used herein shall mean Credit Suisse Securities (USA) LLC, as the sole Underwriter. This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company by the Underwriters.
EX-1.1 2 d396029dex11.htm UNDERWRITING AGREEMENT 5,738,637 SHARES STERLING FINANCIAL CORPORATION COMMON STOCK, HAVING NO PAR VALUE UNDERWRITING AGREEMENT August 14, 2012 FBR Capital Markets & Co.Underwriting Agreement • May 5th, 2020 • New York
2,000,000 Shares of Common Stock BIOXCEL THERAPEUTICS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 21st, 2020 • BioXcel Therapeutics, Inc. • Pharmaceutical preparations • New York
In connection with this offering of the Stock and conditional upon the exercise of the option to purchase up to 300,000 additional shares of Option Stock, the Company has agreed to repurchase from BioXcel Corporation (the “Holder”), in a privately negotiated transaction, up to 400,000 shares at the Purchase Price (as defined in Section 2) (the “Repurchase”) pursuant to the Stock Purchase Agreement, dated as of February 18, 2020, by and between the Company and the Holder (the “Repurchase Agreement”).
● ] shares of Class A Common Stock THE AZEK COMPANY INC. (SUCCESSOR TO CPG NEWCO LLC) UNDERWRITING AGREEMENTUnderwriting Agreement • February 7th, 2020 • CPG Newco LLC • Plastics products, nec • New York
The AZEK Company Inc. (successor to CPG Newco LLC), a Delaware corporation (the “Company”), proposes to sell [ ● ] shares (the “Firm Stock”) of the Company’s Class A common stock, par value $0.001 per share (the “Common Stock”). In addition, the Company proposes to grant to the underwriters named in Schedule I (the “Underwriters”) attached to this agreement (this “Agreement”) an option to purchase up to an aggregate of [ ● ] additional shares of the Common Stock on the terms set forth in Section 2 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock”. This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company by the Underwriters.
2,303,030 Shares of Common Stock BIOXCEL THERAPEUTICS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • September 27th, 2019 • BioXcel Therapeutics, Inc. • Pharmaceutical preparations • New York
BioXcel Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to sell 2,303,030 shares (the “Firm Stock”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). In addition, the Company proposes to grant to the underwriters named in Schedule I (the “Underwriters”) attached to this agreement (this “Agreement”) an option to purchase up to 345,454 additional shares of the Common Stock on the terms set forth in Section 2 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock”. This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company by the Underwriters.
Advanced Drainage Systems, Inc. Common Stock, $0.01 par value per share UNDERWRITING AGREEMENTUnderwriting Agreement • September 10th, 2019 • Advanced Drainage Systems, Inc. • Plastics foam products • New York
Advanced Drainage Systems, Inc. a Delaware corporation (the “Company”), proposes to sell 9,000,000 shares (the “Firm Stock”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”). In addition, the Company proposes to grant to the underwriters named in Schedule I (the “Underwriters”) attached to this agreement (this “Agreement”) an option to purchase up to 1,350,000 additional shares of the Common Stock on the terms set forth in Section 2 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock”. This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company by the Underwriters.
Palomar Holdings, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • April 8th, 2019 • Palomar Holdings, Inc. • Fire, marine & casualty insurance • New York
Palomar Holdings, Inc., a Delaware corporation (the “Company”), proposes to sell [·] shares (the “Firm Stock”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). In addition, the Company proposes to grant to the underwriters named in Schedule I (the “Underwriters”) attached to this agreement (this “Agreement”) an option to purchase up to [·] additional shares of the Common Stock on the terms set forth in Section 2 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock”. This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company by the Underwriters.
1,739,000 Shares STAAR Surgical Company Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • August 10th, 2018 • Staar Surgical Co • Ophthalmic goods • New York
Canaccord Genuity LLC As Representative of the several Underwriters named in Schedule 1 attached hereto, 99 High Street, Suite 1200 Boston, Massachusetts 02110
6,600,000 Shares Maxwell Technologies, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • August 9th, 2018 • Maxwell Technologies Inc • Miscellaneous electrical machinery, equipment & supplies • New York
Maxwell Technologies, Inc., a Delaware corporation (the “Company”), proposes to sell 6,600,000 shares (the “Firm Stock”) of the Company’s common stock, par value $0.10 per share (the “Common Stock”). In addition, the Company proposes to grant to the underwriters named in Schedule I (the “Underwriters”) attached to this agreement (this “Agreement”) an option to purchase up to 990,000 additional shares of the Common Stock on the terms set forth in Section 2 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock”. This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company by the Underwriters.
5,463,237 Shares Carbonite, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • July 20th, 2018 • Carbonite Inc • Services-computer processing & data preparation • New York
Carbonite, Inc., a Delaware corporation (the “Company”), and the David Friend 2009 Revocable Trust (the “Selling Stockholder”), propose to sell an aggregate of 5,463,237 shares (the “Firm Stock”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”). Of the 5,463,237 shares of the Firm Stock, 4,765,157 are being sold by the Company and 698,080 are being sold by the Selling Stockholder. In addition, the Company proposes to grant to the underwriters named in Schedule I (the “Underwriters”) attached to this agreement (this “Agreement”) an option to purchase up to an aggregate of 819,485 additional shares of the Common Stock on the terms set forth in Section 3 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock”. This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company and the Selling Stockholder by the Underwriters.
5,360,000 Shares RING ENERGY, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 27th, 2018 • Ring Energy, Inc. • Crude petroleum & natural gas • New York
Ring Energy, Inc., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions of this Underwriting Agreement (this “Agreement”), to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters”), 5,360,000 shares (the “Firm Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). In addition, the Company proposes to grant to the Underwriters an option to purchase up to 804,000 additional shares of Common Stock on the terms set forth in Section 2 (the “Option Shares”). The Firm Shares and, if and to the extent such option is exercised, the Option Shares, are hereinafter collectively called the “Shares.”
BIOXCEL THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 12th, 2018 • BioXcel Therapeutics, Inc. • Pharmaceutical preparations • New York
BioXcel Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to sell [ · ] shares (the “Firm Stock”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). In addition, the Company proposes to grant to the underwriters named in Schedule I (the “Underwriters”) attached to this agreement (this “Agreement”) an option to purchase up to [·] additional shares of the Common Stock on the terms set forth in Section 2 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock”. This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company by the Underwriters.
8,000,000 Shares HALCÓN RESOURCES CORPORATION Common Stock Underwriting AgreementUnderwriting Agreement • February 8th, 2018 • Halcon Resources Corp • Crude petroleum & natural gas • New York
Halcón Resources Corporation, a Delaware corporation (the “Company”), proposes to sell 8,000,000 shares of common stock (the “Firm Stock”), par value $0.0001 per share (the “Common Stock”), to the underwriters named in Schedule 1 (the “Underwriters”) attached to this agreement (this “Agreement”) for whom J.P. Morgan Securities LLC (the “Representative”) is acting as representative. In addition, the Company proposes to grant to the Underwriters an option to purchase up to 1,200,000 additional shares of the Common Stock on the terms set forth in Section 3 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock.” This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company by the Underwriters.
●] Shares of WatchGuard Video, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • October 19th, 2017 • WatchGuard, Inc. • Radio & tv broadcasting & communications equipment • New York
WatchGuard, Inc., a Delaware corporation (the “Company”) and certain stockholders of the Company named in Schedule II attached hereto (the “Selling Stockholders”), proposes to sell an aggregate of [●] shares (the “Firm Stock”) of the Company’s common stock, par value $[●] per share (the “Common Stock”). Of the [●] shares of the Firm Stock, [●] are being sold by the Company and [●] are being sold by the Selling Stockholders. In addition, the Selling Stockholders propose to grant to the underwriters named in Schedule I (the “Underwriters”) attached to this agreement (this “Agreement”) an option to purchase up to an aggregate of [●] additional shares of the Common Stock on the terms set forth in Section 3 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock.” This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company and the Selling Stockholders by the Underwriters.
TETRAPHASE PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • July 28th, 2017 • Tetraphase Pharmaceuticals Inc • Pharmaceutical preparations • New York
Tetraphase Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to sell 10,000,000 shares (the “Firm Stock”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). In addition, the Company proposes to grant to the underwriters (the “Underwriters”) named in Schedule I attached to this agreement (this “Agreement”) an option to purchase up to 1,500,000 additional shares of the Common Stock on the terms set forth in Section 2 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock”. This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company by the Underwriters.
4,500,000 Shares RING ENERGY, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • July 21st, 2017 • Ring Energy, Inc. • Crude petroleum & natural gas • New York
